"I want patients to understand their options and have choices."
- Ann H. Partridge, MD, MPH
"We need to tailor therapies better for individual patients….the problem is that we overtreat the many to benefit the few."
- Lawrence J. Solin, MD
"There is risk both with treatment and with treatment deescalation, and we need to be able to quantify that trade off in a much better way for an individual patient."
- Shelley Hwang, MD, MPH
"The next few years will witness the publication of major trial results and potentially chart a new course of DCIS management."
- Lars J. Grimm, MD, MHS
We’re excited to share a powerful new conversation on the Out of Patients with Matthew Zachary podcast, where DCIS Understood founder, Julia Stalder, discusses DCIS, active surveillance, and why the phrase “the best kind of breast cancer” can be so misleading. In the episode, titled “The Nicest Bus in Cancer,” Julia reflects on her own diagnosis and the broader challenges facing DCIS patients today.
Subscribe below for the latest DCIS news and updates.